CLINICAL_TRIALS
trial_result
· 2010-10-15
Clinical Trial Update: Single Dose PG102 in Patients With Active Psoriatic Arthritis [Phase 1]
Summary
A Phase 1 study of a single-dose PG102 in patients with active psoriatic arthritis was terminated; results were posted on 2010-10-15.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PanGenetics UK Limited | Conditions: Arthritis, Psoriatic | Phase 1 | Status: TERMINATED | Results posted: 2010-10-15